Survival of bronchopulmonary cancers according to radon exposure
- PMID: 38328545
- PMCID: PMC10847230
- DOI: 10.3389/fpubh.2023.1306455
Survival of bronchopulmonary cancers according to radon exposure
Abstract
Introduction: Residential exposure is estimated to be responsible for nearly 10% of lung cancers in 2015 in France, making it the second leading cause, after tobacco. The Auvergne-Rhône-Alpes region, in the southwest of France, is particularly affected by this exposure as 30% of the population lives in areas with medium or high radon potential. This study aimed to investigate the impact of radon exposure on the survival of lung cancer patients.
Methods: In this single-center study, patients with a histologically confirmed diagnosis of lung cancer, and newly managed, were prospectively included between 2014 and 2020. Univariate and multivariate survival analyses were carried out using a non-proportional risk survival model to consider variations in risk over time.
Results: A total of 1,477 patients were included in the analysis. In the multivariate analysis and after adjustment for covariates, radon exposure was not statistically associated with survival of bronchopulmonary cancers (HR = 0.82 [0.54-1.23], HR = 0.92 [0.72-1.18], HR = 0.95 [0.76-1.19] at 1, 3, and 5 years, respectively, for patients residing in category 2 municipalities; HR = 0.87 [0.66-1.16], HR = 0.92 [0.76-1.10], and HR = 0.89 [0.75-1.06] at 1, 3, and 5 years, respectively, for patients residing in category 3 municipalities).
Discussion: Although radon exposure is known to increase the risk of lung cancer, in the present study, no significant association was found between radon exposure and survival of bronchopulmonary cancers.
Keywords: environmental exposure; lung cancer; public health; radon; survival.
Copyright © 2024 Dessemon, Perol, Chauvel, Noelle, Coudon, Grassot, Foray, Belladame, Fayette, Fournie, Swalduz, Neidhart, Saintigny, Tabutin, Boussageon, Gomez, Avrillon, Perol, Charbotel and Fervers.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
References
-
- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. (2020). Global Cancer observatory: Cancer today. Available at: http://gco.iarc.fr/today/home (Accessed December 30, 2022).
-
- International Agency for Research on Cancer (IARC) (2012). Radiation. Vol 100D. IARC. Available at: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-T... (Accessed December 30, 2022).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
